Azitra, Inc.

AZTR · NYSE · SIC 2834: Pharmaceutical Preparations
75
SEC Filings

Business Summary

PART I Background Azitra, Inc. was formed as a Delaware corporation on January 2, 2014 as a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Since our formation, we have built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for unique therapeutic characteristics. The platform is augmented by an ar...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAZTRdiscussed_in_filing Artificial Intelligence
topic_mentionAZTRdiscussed_in_filing Cybersecurity
topic_mentionAZTRdiscussed_in_filing Trusted Computing
topic_mentionAZTRdiscussed_in_filing Blockchain & Crypto
topic_mentionAZTRdiscussed_in_filing Regulation
topic_mentionAZTRdiscussed_in_filing Healthcare & Bio
topic_mentionAZTRdiscussed_in_filing Platform & Ecosystem
topic_mentionAZTRdiscussed_in_filing Sovereign & Government
topic_mentionAZTRdiscussed_in_filing Artificial Intelligence
topic_mentionAZTRdiscussed_in_filing Cybersecurity
topic_mentionAZTRdiscussed_in_filing Trusted Computing
topic_mentionAZTRdiscussed_in_filing Blockchain & Crypto
topic_mentionAZTRdiscussed_in_filing Regulation
topic_mentionAZTRdiscussed_in_filing Healthcare & Bio
topic_mentionAZTRdiscussed_in_filing Platform & Ecosystem
topic_mentionAZTRdiscussed_in_filing Sovereign & Government
topic_mentionAZTRdiscussed_in_filing Artificial Intelligence
topic_mentionAZTRdiscussed_in_filing Cybersecurity
topic_mentionAZTRdiscussed_in_filing Trusted Computing
topic_mentionAZTRdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001701478-26-000013EDGAR80K words
2025-02-242024-12-310001701478-25-000012EDGAR—
2024-03-152023-12-310001493152-24-010091EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001701478-25-000050EDGAR21K words
2025-08-112025-06-300001701478-25-000040EDGAR—
2025-05-132025-03-310001701478-25-000018EDGAR—
2024-11-122024-09-300001701478-24-000012EDGAR—
2024-08-122024-06-300001701478-24-000009EDGAR—
2024-05-092024-03-310001701478-24-000005EDGAR—
2023-11-142023-09-300001493152-23-041056EDGAR—
2023-08-142023-06-300001493152-23-028455EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001493152-26-012084EDGAR18K words
2026-03-130001493152-26-010108EDGAR—
2026-03-050001493152-26-009003EDGAR—
2026-02-270001701478-26-000014EDGAR—
2026-02-060001493152-26-005564EDGAR—
2025-12-170001493152-25-028148EDGAR—
2025-11-250001493152-25-025001EDGAR—
2025-11-120001701478-25-000051EDGAR—
2025-10-030001493152-25-016887EDGAR—
2025-08-290001493152-25-012476EDGAR—

75 total filings indexed. 54 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001701478
TickerAZTR
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4b5cb497256c18c243efa2f179ff611d06a662702c21d4866b6a345b1f3ef654
parent: b678c4bdd083808ccef273aa4d3754d05b7fecc1ee02733c224c6eadf72e39f1
content hash: e573ba322a28b791c2752a0ef3238377bbca239dc67aae741d721a28e753aa6c
signed: 2026-04-13T04:43:51.211Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf